351 related articles for article (PubMed ID: 21605997)
21. Recent advances in the fight against leishmaniasis with natural products.
Akendengue B; Ngou-Milama E; Laurens A; Hocquemiller R
Parasite; 1999 Mar; 6(1):3-8. PubMed ID: 10229931
[TBL] [Abstract][Full Text] [Related]
22. Topical treatment for cutaneous leishmaniasis.
Garnier T; Croft SL
Curr Opin Investig Drugs; 2002 Apr; 3(4):538-44. PubMed ID: 12090720
[TBL] [Abstract][Full Text] [Related]
23. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
[TBL] [Abstract][Full Text] [Related]
24. Pentavalent antimonials: new perspectives for old drugs.
Frézard F; Demicheli C; Ribeiro RR
Molecules; 2009 Jun; 14(7):2317-36. PubMed ID: 19633606
[TBL] [Abstract][Full Text] [Related]
25. Leishmanicidal activity of benzophenones and extracts from Garcinia brasiliensis Mart. fruits.
Pereira IO; Marques MJ; Pavan AL; Codonho BS; Barbiéri CL; Beijo LA; Doriguetto AC; D'Martin EC; dos Santos MH
Phytomedicine; 2010 Apr; 17(5):339-45. PubMed ID: 19762221
[TBL] [Abstract][Full Text] [Related]
26. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
Da Silva BJM; Hage AAP; Silva EO; Rodrigues APD
J Integr Med; 2018 Jul; 16(4):211-222. PubMed ID: 29691188
[TBL] [Abstract][Full Text] [Related]
27. Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs.
Rajasekaran R; Chen YP
Drug Discov Today; 2015 Aug; 20(8):958-68. PubMed ID: 25936844
[TBL] [Abstract][Full Text] [Related]
28. New approaches from nanomedicine for treating leishmaniasis.
Gutiérrez V; Seabra AB; Reguera RM; Khandare J; Calderón M
Chem Soc Rev; 2016 Jan; 45(1):152-68. PubMed ID: 26487097
[TBL] [Abstract][Full Text] [Related]
29. Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
Harzallah K; Belhadj R; Jemli B; Haloues M; Berraies N; Gargouri S; Hmida J; Battikh R; Manaa J
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):105-8. PubMed ID: 20061702
[TBL] [Abstract][Full Text] [Related]
30. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.
Calza L; D'Antuono A; Marinacci G; Manfredi R; Colangeli V; Passarini B; Orioli R; Varoli O; Chiodo F
J Am Acad Dermatol; 2004 Mar; 50(3):461-5. PubMed ID: 14988693
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of the immunomodulatory extract of Kalanchoe pinnata against murine visceral leishmaniasis.
Gomes DC; Muzitano MF; Costa SS; Rossi-Bergmann B
Parasitology; 2010 Apr; 137(4):613-8. PubMed ID: 19961648
[TBL] [Abstract][Full Text] [Related]
32. Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata.
Ferreira ME; de Arias AR; Yaluff G; de Bilbao NV; Nakayama H; Torres S; Schinini A; Guy I; Heinzen H; Fournet A
Phytomedicine; 2010 Apr; 17(5):375-8. PubMed ID: 19879121
[TBL] [Abstract][Full Text] [Related]
33. Anti-leishmanial and immunomodulatory activities of extracts from Portulaca hirsutissima and Portulaca werdermannii.
Costa JF; Kiperstok AC; David JP; David JM; Giulietti AM; de Queiroz LP; dos Santos RR; Soares MB
Fitoterapia; 2007 Dec; 78(7-8):510-4. PubMed ID: 17651913
[TBL] [Abstract][Full Text] [Related]
34. Ta'ta', Huayani: perception of leishmaniasis and evaluation of medicinal plants used by the Chayahuita in Peru. Part II.
Odonne G; Bourdy G; Castillo D; Estevez Y; Lancha-Tangoa A; Alban-Castillo J; Deharo E; Rojas R; Stien D; Sauvain M
J Ethnopharmacol; 2009 Oct; 126(1):149-58. PubMed ID: 19631728
[TBL] [Abstract][Full Text] [Related]
35. Fishing for anti-leishmania drugs: principles and problems.
Handman E; Kedzierski L; Uboldi AD; Goding JW
Adv Exp Med Biol; 2008; 625():48-60. PubMed ID: 18365658
[TBL] [Abstract][Full Text] [Related]
36. Current approaches to discover marine antileishmanial natural products.
Tempone AG; Martins de Oliveira C; Berlinck RG
Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
[TBL] [Abstract][Full Text] [Related]
37. [Importance of drug carriers in the treatment of visceral leishmaniasis].
Fusai T; Durand R; Boulard Y; Paul M; Bories C; Rivollet D; Houin R; Deniau M
Med Trop (Mars); 1995; 55(1):73-8. PubMed ID: 7637615
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of antiprotozoal and plasmodial enoyl-ACP reductase inhibition potential of turkish medicinal plants.
Tasdemir D; Brun R; Perozzo R; Dönmez AA
Phytother Res; 2005 Feb; 19(2):162-6. PubMed ID: 15852483
[TBL] [Abstract][Full Text] [Related]
39. Leishmanicidal activity of Pentalinon andrieuxii.
Lezama-Dávila CM; Isaac-Márquez AP; Zamora-Crescencio P; Uc-Encalada Mdel R; Justiniano-Apolinar SY; del Angel-Robles L; Satoskar A; Hernández-Rivero L
Fitoterapia; 2007 Apr; 78(3):255-7. PubMed ID: 17355903
[TBL] [Abstract][Full Text] [Related]
40. Imported cutaneous leishmaniasis in Thailand.
Viriyavejakul P; Viravan C; Riganti M; Punpoowong B
Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):558-62. PubMed ID: 9561608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
